Hasse Khiabani Zaré
- Group leader; MD, PhD
- +47 23 07 08 98
Publications 2024
Effect on QTc interval by switching from methadone to equipotent R-methadone dose in methadone maintenance treatment patients
Basic Clin Pharmacol Toxicol, 134 (4), 519-530
DOI 10.1111/bcpt.13982, PubMed 38308508
Acute effects of oral mesna administration on the full amino acid profile and 3-methylhistidine: secondary results from the CYLOB dose-finding study
Amino Acids, 56 (1), 39
DOI 10.1007/s00726-024-03398-2, PubMed 38844567
Publications 2023
Intraindividual Variability in Absolute Bioavailability and Clearance of Midazolam in Healthy Individuals
Clin Pharmacokinet, 62 (7), 981-987
DOI 10.1007/s40262-023-01257-z, PubMed 37162619
Cysteine-lowering treatment with mesna against obesity: Proof of concept and results from a human phase I, dose-finding study
Diabetes Obes Metab, 25 (11), 3161-3170
DOI 10.1111/dom.15210, PubMed 37435697
Publications 2020
Chronic Inhibition of CYP3A is Temporarily Reduced by Each Hemodialysis Session in Patients With End-Stage Renal Disease
Clin Pharmacol Ther, 108 (4), 866-873
DOI 10.1002/cpt.1875, PubMed 32356565
Publications 2019
Pharmacokinetics of a novel, approved, 1.4-mg intranasal naloxone formulation for reversal of opioid overdose-a randomized controlled trial
Addiction, 114 (5), 859-867
DOI 10.1111/add.14552, PubMed 30644628
Publications 2017
The novel combination of theophylline and bambuterol as a potential treatment of hypoxemia in humans
Can J Physiol Pharmacol, 95 (9), 1009-1018
DOI 10.1139/cjpp-2016-0635, PubMed 28467859
Publications 2008
Drug screening of hair by liquid chromatography-tandem mass spectrometry
J Anal Toxicol, 32 (5), 364-72
DOI 10.1093/jat/32.5.364, PubMed 18544222
Publications 2007
Rapid quantification of buprenorphine-glucuronide and norbuprenorphine-glucuronide in human urine by LC-MS-MS
J Anal Toxicol, 31 (4), 214-9
DOI 10.1093/jat/31.4.214, PubMed 17555645
Publications 2001
The concentration of protein-compounds in interstitial tissue of patients with chronic critical limb ischaemia and oedema
Vasa, 30 (1), 14-20
DOI 10.1024/0301-1526.30.1.14, PubMed 11284084
Publications 2000
Alterations in capillary permeability in the lower limb of patients with chronic critical limb ischaemia and oedema
Vasa, 29 (2), 106-11
DOI 10.1024/0301-1526.29.2.106, PubMed 10901087
Patterns of skin flowmotion in the lower limbs of patients with chronic critical limb ischaemia (CLI) and oedema
Eur J Vasc Endovasc Surg, 20 (6), 536-44
DOI 10.1053/ejvs.2000.1225, PubMed 11136589
Vascular and stromal features in the skin of the lower limb in patients with chronic critical limb ischaemia (CLI) and oedema
Eur J Vasc Endovasc Surg, 20 (2), 125-31
DOI 10.1053/ejvs.2000.1142, PubMed 10942683
Transcapillary forces and the development of oedema in the lower limb of patients with chronic critical limb ischaemia (CLI)
Eur J Vasc Endovasc Surg, 19 (6), 598-604
DOI 10.1053/ejvs.2000.1073, PubMed 10873727
The role of the veno-arteriolar reflex (VAR) in the pathogenesis of peripheral oedema in patients with chronic critical limb ischaemia (CLI)
Ann Chir Gynaecol, 89 (2), 93-8
PubMed 10905673
Publications 1999
The distribution of oedema in the lower limb of patients with chronic critical limb ischaemia: a study with computed tomography
Vasa, 28 (4), 265-70
DOI 10.1024/0301-1526.28.4.265, PubMed 10611844
Oedema in the lower limb of patients with chronic critical limb ischaemia (CLI)
Eur J Vasc Endovasc Surg, 17 (5), 419-23
DOI 10.1053/ejvs.1998.0801, PubMed 10329526